The main component of digital therapeutics in type 2 diabetes management is to engage people with diabetes (PWD) in self-care management. The digital interactions related to self-monitoring of blood glucose (SMBG) and insulin titration use sophisticated algorithms of care that produce improvement in outcomes. However, little is known on the behavior change theories used to support the engagement needed to produce ongoing usage and optimize outcomes. The aim of this oral presentation is to examine the behavior change theories used in the development and deployment of insulin titration apps and SMBG related digital therapeutics.
This will be an oral presentation of literature review about the use of the behavioral change theories used in development and deployment of digital therapeutics related to insulin titration apps and SMBG.
Using evidence-based behavior change theories and philosophy is instrumental for individualization and scalability of the digital therapeutics. Utilization of behavioral theories in digital therapeutics transform the evidence of effective interventions where PWD are empowered, create concordance, activation, and engagement.
The use of behavioral change theories in development and use of digital therapeutics impacts the cognitive, affective, and behavioral experience for the users.